Last Price
0.02
Today's Change
-0.002 (9.09%)
Day's Change
0.019 - 0.022
Trading Volume
9,345,827
Market Cap
15 Million
Shares Outstanding
787 Million
Avg Volume
1,015,031
Avg Price (50 Days)
0.02
Avg Price (200 Days)
0.02
PE Ratio
-0.67
EPS
-0.03
Earnings Announcement
31-May-2025
Previous Close
0.02
Open
0.02
Day's Range
0.019 - 0.022
Year Range
0.012 - 0.031
Trading Volume
9,345,827
1 Day Change
-9.09%
5 Day Change
-4.76%
1 Month Change
-9.09%
3 Month Change
-13.04%
6 Month Change
-28.57%
Ytd Change
-21.37%
1 Year Change
-20.00%
3 Year Change
-91.67%
5 Year Change
-87.88%
10 Year Change
-88.89%
Max Change
-88.89%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a digital pregnancy monitor platform for the creation and implementation of digital health solutions for maternity care management. It also develops EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.